HEALTH

CureVac: Over 100 Million vaccines to be produced

TÜBINGEN – CureVac N.V. (Nasdaq: CVAC), a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) and Celonic Group, a premium biopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in the development and production … Continue reading CureVac: Over 100 Million vaccines to be produced